Fisher Asset Management disclosed new stakes in COIN and CRSP, betting on Coinbase’s expanded market share and product diversification to drive growth as crypto markets show signs of recovery.
Ken Fisher's fund opened a new position in Coinbase, and the article highlights record market share and potential for a rally as crypto markets recover.
Bitcoin's price advance is cited as a catalyst for crypto-related equities like Coinbase.
Fisher Asset Management initiated a new position in CRISPR Therapeutics, signaling investor confidence.
Billionaire Ken Fisher’s asset management firm initiated new positions in Coinbase Global and CRISPR Therapeutics during the second quarter. While Coinbase faces headwinds from declining transaction revenue, the firm achieved a record 10.3% market share, positioning it to capitalize on a potential rebound in cryptocurrency prices.
Fisher's investment reflects confidence in Coinbase's record market share growth and its strategic shift toward diversifying revenue streams beyond traditional crypto trading.
The company remains highly sensitive to crypto price volatility and retail participation, while increased regulatory clarity could invite competition from traditional financial firms.